CARDIOVASCULAR EFFECTS OF FIBRINOPEPTIDE-B

被引：5

作者：

MOORE, PK

HUSSAINI, I

BHARDWAJ, R

机构：

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1988年 / 40卷 / 08期

基金：

英国惠康基金;

关键词：

D O I：

10.1111/j.2042-7158.1988.tb05302.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：558 / 561

页数：4

相关论文

共 11 条

[1] IDENTIFICATION OF 6-OXO-PROSTAGLANDIN-E1 AS A NATURALLY-OCCURRING PROSTANOID GENERATED BY RAT LUNG
BERRY, CN
GRIFFITHS, RJ
HOULT, JRS
MOORE, PK
TAYLOR, GW
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (02) : 327 - 335
[2] FLAMENBAUM W, 1977, PROSTAGLANDINS, V3, P267
[3] NATURE OF PEPTIDES RELEASED BY THROMBIN
GLADNER, JA
LAKI, K
MURTAUGH, PA
FOLK, JE
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1963, 104 (01) : 47 - &
[4] A COMPARATIVE-STUDY OF THE INVOLVEMENT OF THE PROSTAGLANDIN-H2 THROMBOXANE-A2 PATHWAY IN INTRAVASCULAR PLATELET-AGGREGATION IN GUINEA-PIGS AND RATS
MALLARKEY, G
SMITH, GM
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1985, 84 (02) : 425 - 430
[5] MEADE TW, 1984, LANCET, V2, P607
[6] SULPHASALAZINE ANALOG PH-CH-44A - POWERFUL AND SELECTIVE INHIBITOR OF PROSTAGLANDIN BREAKDOWN INVITRO AND INVIVO
MOORE, PK
RAMCHARAN, E
HOULT, JRS
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 61 (03) : 287 - 292
[7] FIBRINOPEPTIDE RELEASE FROM FIBRINOGEN
NOSSEL, HL
HURLETJENSEN, A
LIU, CY
KOEHN, JA
CANFIELD, RE
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 408 (JUN) : 269 - 278
[8] MEASUREMENT OF FIBRINOPEPTIDE-A IN HUMAN-BLOOD
NOSSEL, HL
YUDELMAN, I
CANFIELD, RE
BUTLER, VP
SPANONDIS, K
WILNER, GD
QURESHI, GD
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (01) : 43 - 53
[9] OSBAHR AJ, 1967, NATURE, V215, P292
[10] PACEASCIAK CR, 1982, PROG LIPID RES, V20, P605